job_11 : Yes, buy before 21 Feb.

job_11 : Yes, I am adding more. Total number of shares are only 5.59M only. Potential high value later on.

job_11 : If below 100, I have checked, and there are no fractional shares issued or cash payment made. It's gone.

job_11 : Outdated report. Latest report is in the announcement.

job_11 : Should have 3 shares. If fractional shares, most companies will round down and pay cash for the fractional portion based on the post-split share price.

job_11 : Why not nice? Scare price will drop to below $1 again?

job_11 : There aren't much news or new developments except for positive Phase 1/2 clinical data from trial for VYD2311 and better preliminary fourth quarter 2024 financial results. The only reason I can think about why the price closed above $1 is to regain compliance with Nasdaq's minimum bid price requirement as the company has until June 25, 2025 to do so.

job_11 : Price may fall after the 10 consecutive trading days.